Click here for answers to questions regarding COVID-19!
New

Mirataz Transdermal Ointment 5g Tube

PVS8600

Mirataz™ is a transdermal ointment containing mirtazapine.  It is the first FDA-approved transdermal medication for the management of weight loss in cats. 

  • In clinical studies, Mirataz resulted in significant weight gain in cats in as little as 14 days following topical application of 2mg per day
  • Gives clients a practical way to manage their cat's weight loss without administration of oral medication and does not rely on the cat to eat to be medicated
  • Mirataz achieves measurable plasma concentrations of mirtazapine in cats using proprietary Accusorb™ technology.
  • Well tolerated both locally and systemically in clinical studies
  • View the detailed product information for more detailed information and study reference

NEW extended shelf life of 48 months!

Log-in to purchase
Complementary Content
${loading}